Cardiff Oncology Inc.
(CRDF)
undefined
undefined%
At close: undefined
4.65
2.39%
After-hours Jan 06, 2025, 07:45 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY05 | FY04 |
| Net Income | -41.44M | -38.70M | -28.29M | -19.31M | -16.41M | -16.46M | -24.91M | -39.20M | -27.47M | -14.33M | -11.81M | -11.57M | -2.24M | -5.45M | -2.48M | -7.84M | n/a |
| Depreciation & Amortization | 398.00K | 236.00K | 451.00K | 466.01K | 494.00K | 859.00K | 1.25M | 1.07M | 378.71K | 234.81K | 130.52K | 37.84K | 10.29K | 8.39K | 50.00K | 28.95K | n/a |
| Stock-Based Compensation | 4.51M | 4.26M | 3.23M | 1.76M | 885.00K | 2.17M | 4.01M | 7.50M | 3.95M | 2.07M | 1.98M | 532.14K | 250.98K | 325.93K | n/a | n/a | n/a |
| Other Working Capital | 3.25M | -1.49M | -2.29M | -654.53K | 1.09M | -23.75K | 2.94B | -789.74K | -37.30K | -258 | 25.63K | -17.38K | 21.65K | 95.39K | -360.00K | -27.62K | n/a |
| Other Non-Cash Items | -921.00K | 772.00K | 2.03M | 1.10M | 703.00K | 764.00K | 1.24M | 964.00K | 434.28K | 305.92K | 198.79K | 6.89M | -2.18M | -2.69M | 1.56M | -174.69K | n/a |
| Deferred Income Tax | n/a | n/a | 1.32M | 315.01K | -28.00K | -635.00K | -1.75M | -2.46M | 730.98K | -1.45M | 1.11M | n/a | 1.62M | 5.67M | n/a | -27.62K | n/a |
| Change in Working Capital | 6.57M | -380.00K | -1.79M | -654.53K | 1.09M | 98.00K | -3.13M | 1.09M | -137.93K | 437.87K | 1.08M | -824.38K | 610.07K | 48.36K | -360.00K | 27.62K | n/a |
| Operating Cash Flow | -30.89M | -33.82M | -23.04M | -16.31M | -13.27M | -13.20M | -23.28M | -31.04M | -22.12M | -12.73M | -7.32M | -4.93M | -1.93M | -2.09M | -1.23M | -4.40M | n/a |
| Capital Expenditures | -582.00K | -892.00K | -205.00K | -211.88K | -68.00K | -5.10K | -100.00K | -823.00K | -2.24M | -363.29K | -649.28K | -270.08K | -1.53K | -27.75K | -10.00K | n/a | n/a |
| Acquisitions | n/a | -114.00K | 205.00K | n/a | n/a | 5.10K | 109.91M | 809.73M | 7.60K | n/a | n/a | n/a | n/a | -104.70K | n/a | n/a | n/a |
| Purchase of Investments | -70.08M | -91.23M | -174.38M | n/a | n/a | -31.50K | -8.80M | -24.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 106.86M | 130.27M | 43.14M | n/a | n/a | 31.50K | 24.06M | 13.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 114.00K | -205.00K | n/a | n/a | 23.00K | -101.10M | -823.48M | 7.60K | 63.50K | 500.00 | 4.00K | n/a | n/a | n/a | -72.98K | n/a |
| Investing Cash Flow | 36.20M | 38.15M | -131.45M | -211.88K | -68.00K | 23.00K | 23.96M | -24.83M | -2.23M | -299.79K | -649.28K | -270.08K | -1.53K | -132.45K | -10.00K | -72.98K | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | -1.38M | -17.24M | -351.00K | 1.09M | 14.48M | 515.96K | n/a | n/a | n/a | 44.55K | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.47M | n/a | n/a |
| Dividend Paid | n/a | -414.00K | -24.00K | -24.24M | -24.24M | -24.24M | -24.24M | -24.24M | -24.24M | -23.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | 75.00K | 1.29M | 49.25M | 27.50M | 30.24M | -866.04K | 24.53M | 26.49M | n/a | 22.47M | 600.00 | n/a | n/a | 140.45K | 5.11M | n/a |
| Financial Cash Flow | n/a | 75.00K | 35.45M | 137.31M | 12.08M | 16.40M | -6.38M | 2.30M | 64.55M | 14.48M | 22.98M | 15.32M | 2.57M | 1.73M | 1.65M | 5.11M | n/a |
| Net Cash Flow | 5.31M | 4.40M | -119.04M | 120.79M | -1.26M | 3.23M | -5.69M | -53.58M | 40.20M | 1.46M | 15.02M | 10.12M | 641.67K | -486.46K | 410.00K | 638.13K | n/a |
| Free Cash Flow | -31.47M | -34.71M | -23.25M | -16.53M | -13.34M | -13.21M | -23.38M | -31.86M | -24.36M | -13.09M | -7.97M | -5.20M | -1.93M | -2.12M | -1.24M | -4.40M | n/a |